Canandaigua National Corp Becton Dickinson & CO Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Canandaigua National Corp holds 5,551 shares of BDX stock, worth $1.25 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

5,551

Previous 5,226 6.22%

Holding current value

$1.25 Million

Previous $1.17 Million 21.2%

% of portfolio

0.24%

Previous 0.21%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$218.29 - $256.91 $70,944 - $83,495	325 Added 6.22%	5,551 $1.41 Million
Q3 2022 Oct 05, 2022	SELL	$51.03 - $264.23 $6,123 - $31,707	-120 Reduced 2.24%	5,226 $1.17 Million
Q2 2022 Jul 05, 2022	BUY	$234.74 - $275.42 $192,956 - $226,395	822 Added 18.17%	5,346 $1.32 Million
Q1 2022 May 09, 2022	BUY	$243.64 - $270.48 $37,033 - $41,112	152 Added 3.48%	4,524 $1.2 Million
Q4 2021 Jan 04, 2022	BUY	$230.08 - $250.94 $9,203 - $10,037	40 Added 0.92%	4,372 $1.1 Million
Q3 2021 Oct 04, 2021	BUY	$232.72 - $256.47 $306,724 - $338,027	1,318 Added 43.73%	4,332 $1.07 Million
Q2 2021 Jul 06, 2021	SELL	$232.65 - $254.58 $84,451 - $92,412	-363 Reduced 10.75%	3,014 $733,000
Q1 2021 Apr 05, 2021	BUY	$232.09 - $256.88 $1,392 - $1,541	6 Added 0.18%	3,377 $821,000
Q4 2020 Feb 11, 2021	BUY	$221.92 - $245.94 $8,654 - $9,591	39 Added 1.17%	3,371 $843,000
Q3 2020 Oct 19, 2020	SELL	$215.77 - $276.76 $29,776 - $38,192	-138 Reduced 3.98%	3,332 $775,000
Q2 2020 Jul 07, 2020	BUY	$219.9 - $263.41 $763,053 - $914,032	3,470 New	3,470 $830,000

Others Institutions Holding BDX

# of Institutions

1,735

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Becton Dickinson & CO Transaction History